To further investigate the expression of the APC endometrial cancer-specific immunotherapy markers, we assessed the protein levels of APC, MLH1, MSH2, MSH6, PMS2, PD-L1, CD3+, and CD8+ by immunohistochemistry using tissues from 99 endometrial cancer tumors. This evidence concerns the gene MSH6 and endometrial cancer.